Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.

Saved in:
Bibliographic Details
Title: Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.
Authors: Masuda H; Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan; Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan., Kobayashi T; Division of Clinical Research Planning, Department of Development Strategy, Center for Clinical Research and Development, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan. Electronic address: torukoba@nifty.com., Hachiya A; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Nagano, Japan., Nakashima Y; Department of Pediatrics, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Fukuoka, Japan., Shimizu H; Children's Medical Center, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan., Nozawa T; Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan., Ogihara Y; Department of Pediatrics, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan., Ito S; Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan; Division of Pediatric Nephrology and Rheumatology, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan., Takatsuki S; Department of Pediatrics, Toho University, Medical Center Omori Hospital, Ota-ku, Tokyo, Japan., Katsumata N; Department of Pediatrics, Faculty of Medicine University of Yamanashi, Chuo, Yamanashi, Japan., Suzuki Y; Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan., Takenaka S; Department of Pediatrics, Japan Community Healthcare Organization (JCHO), Kyusyu Hospital, Kitakyushu, Fukuoka, Japan., Hirono K; Department of Pediatrics, Graduate School of Medicine, University of Toyama, Toyama, Toyama, Japan., Kobayashi T; Division of Cardiology, Gunma Children's Medical Center, Shibukawa, Gunma, Japan., Suzuki H; Department of Pediatrics, Yamagata University School of Medicine, Yamagata, Yamagata, Japan., Suganuma E; Division of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama, Saitama, Japan., Takahashi K; Department of Pathology, Toho University Ohashi Medical Center, Shibuya-ku, Tokyo, Japan., Saji T; Advanced and Integrated Cardiovascular Research Course in the Young and Adolescence, Ota-ku, Toho University, Tokyo, Japan.
Corporate Authors: Committee of Survey on Infliximab use for Kawasaki disease; Japan Society of Kawasaki Disease, Tokyo, Japan.
Source: The Journal of pediatrics [J Pediatr] 2018 Apr; Vol. 195, pp. 115-120.e3. Date of Electronic Publication: 2017 Dec 07.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 0375410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6833 (Electronic) Linking ISSN: 00223476 NLM ISO Abbreviation: J Pediatr Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-6833
DOI:10.1016/j.jpeds.2017.10.013